Japan is preparing to donate an mpox vaccine and injectors made by a domestic firm to the Democratic Republic of Congo (DRC) via the World Health Organization (WHO), Japan’s Minister of Health, Labour and Welfare Keizo Takemi has said.
Japan Prepares For Mpox Vaccine Donation
Manufacturer KM Biologics has confirmed to the Pink Sheet it has filed for an emergency use listing to WHO for its mpox vaccine LC16, which has shown efficacy for post-exposure prophylaxis within 14 days, although its efficacy for pre-exposure prophylaxis is still inconclusive.
More from Middle East & Africa
More from Pink Sheet
• By
Analysts expect a limited impact on South Korean pharma from US tariffs, even if imposed at a later date. Meanwhile, the early June domestic presidential election is set to determine the direction of policies in the sector.
• By
Organizational turmoil has not yet affected reviews of novel agent applications, with Q1 2025 approvals coming in low, but the first quarter share of the entire year is variable.